The present study was conducted to investigate the presence of dog erythrocytic antigen 1 (DEA 1) in breeds, Pug and Dachshund in Kerala, India.Blood samples were collected from sixty dogs belonging to Pug and Dachshund breeds and subjected to immunochromatographic studies.The results elucidated presence of DEA 1 in 90% of the Pugs.were positive for DEA 1.However, 76.67% Dachshunds had DEA 1.The findings revealed that the DEA 1 positive dog population in the area studied was considerably high.

Oxidativestressmanagementhasbeenfoundtohavebeneficialeffects in the management of several disease conditions. A study was conducted to evaluate the efficacy of Coenzyme Q10 supplementation on the total antioxidant status and lipid peroxides levels in dogs with chronic valvular heart disease.Total antioxidant status was measured by Ferric Reducing Antioxidant Power assay and level of lipid peroxides in serum was determined by estimating malonaldialdehyde level. Ten dogs with chronic chronic valvular heart disease were administered with coenzyme Q10 @ 45mg q12h orally for 60 days along with the treatment for management of valvular heart disease.A significant decline in Ferric Reducing Antioxidant Power value was recorded at the end of the study. The malonaldialdehyde levels declined in animals with chronic valvular heart disease by day 60, though reduction was not statistically significant.The administration of Coenzyme Q10 in chronic valvular heart disease may be beneficial in improving the quality of life of the patient.